Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1981-09-25
1984-06-26
Wiseman, Thomas G.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
4351723, 435253, 435317, 435811, 435 68, 435 70, 435 91, C12N 1500, C12N 120, C12N 100, C07H 2104, C12P 2100, C12P 2102, C12P 1934
Patent
active
044567480
ABSTRACT:
Disclosed herein are methods and means of microbially preparing novel human hybrid leukocyte interferons, useful in the treatment of viral and neoplastic diseases, by DNA recombination of parental interferon genes, taking advantage of common restriction endonuclease cleavage sites therein and in carrier expression plasmids.
REFERENCES:
patent: 4262090 (1981-04-01), Colby et al.
Derynck et al., Nature 285, 542, (1980).
Nagata et al., Nature 284, 316, (1980).
Taniguchi et al., Proc. Japan. Acad. 55, Ser. B, 464, (1979).
Nienhuis et al., New Eng. J. Med. 297, 1318, (1977).
Miozzari et al., Nature 277, 486, (1979).
Research Disclosure, Jul. 1979, pp. 351-352, 1351.
Itakura et al., Science 196, 1056, (1977).
Genentech Inc.
Gould George M.
Martinell James
Saxe Jon S.
Wiseman Thomas G.
LandOfFree
Hybrid human leukocyte interferons does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybrid human leukocyte interferons, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybrid human leukocyte interferons will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2233299